212 related articles for article (PubMed ID: 34992654)
1. Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients.
Chen S; Gu J; Zhang Q; Hu Y; Ge Y
J Oncol; 2021; 2021():3375297. PubMed ID: 34992654
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
[TBL] [Abstract][Full Text] [Related]
3. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma.
Yue Z; Wang D; Li X
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439
[TBL] [Abstract][Full Text] [Related]
4. Autophagy-related risk signature based on CDNK2A to facilitate survival prediction of patients with endometrial cancer.
Yue C; Lin B; Sun X; Xu X; Zhou C; Fan J
J Gene Med; 2024 Jan; 26(1):e3648. PubMed ID: 38282156
[TBL] [Abstract][Full Text] [Related]
5. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
[TBL] [Abstract][Full Text] [Related]
6. An anoikis-related gene signature for prediction of the prognosis in prostate cancer.
Zhao X; Wang Z; Tang Z; Hu J; Zhou Y; Ge J; Dong J; Xu S
Front Oncol; 2023; 13():1169425. PubMed ID: 37664042
[TBL] [Abstract][Full Text] [Related]
7. Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients.
Cao J; Hong K; Cao Y; Cen K; Mai Y; Dai Y; Ouyang G; Mu Q; Guo Y
Front Oncol; 2022; 12():1096608. PubMed ID: 36713571
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy.
Liu J; Wang Y; Mei J; Nie S; Zhang Y
Front Cell Dev Biol; 2021; 9():671736. PubMed ID: 34368124
[TBL] [Abstract][Full Text] [Related]
9. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
[No Abstract] [Full Text] [Related]
10. Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer.
Jiang Y; Chen J; Ling J; Zhu X; Jiang P; Tang X; Zhou H; Li R
J Cancer; 2021; 12(5):1431-1444. PubMed ID: 33531988
[No Abstract] [Full Text] [Related]
11. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
[No Abstract] [Full Text] [Related]
12. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
13. Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma.
Liu J; Li S; Feng G; Meng H; Nie S; Sun R; Yang J; Cheng W
Cancer Cell Int; 2020; 20():183. PubMed ID: 32489319
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Chen X; Cao K
Cancer Med; 2021 Dec; 10(23):8693-8707. PubMed ID: 34668665
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis.
Huang S; Pang L; Wei C
Front Genet; 2021; 12():678780. PubMed ID: 34616422
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma.
Chen X; Zhang W; Zhu H; Lin F
Med Sci Monit; 2021 Feb; 27():e928949. PubMed ID: 33577492
[TBL] [Abstract][Full Text] [Related]
18. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.
Yang X; Cheng Y; Li X; Zhou J; Dong Y; Shen B; Zhao L; Wang J
Onco Targets Ther; 2021; 14():2579-2598. PubMed ID: 33880037
[TBL] [Abstract][Full Text] [Related]
19. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
Zhou C; Li C; Yan F; Zheng Y
Cancer Cell Int; 2020 Nov; 20(1):541. PubMed ID: 33292199
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer.
Yang X; Li X; Cheng Y; Zhou J; Shen B; Zhao L; Wang J
Front Cell Dev Biol; 2021; 9():797826. PubMed ID: 35223866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
